May 20, 2010 - Radiation oncologists are increasingly younger practitioners, and there is a larger number of women entering the specialty, according to a report released by The Society of Gynecologic Oncologists (SGO).

The SGO is an organization of board certified women's cancer specialists, has just released the results of a member-based, demographic and practice survey, "Gynecologic Oncology 2010: State of the Subspecialty."

Highlights from the survey include:

- a movement in the profession to younger-aged practitioners and a larger number of women entering the specialty;
- a shift away from private practice as the primary practice setting into salaried positions and an increase in group or multispecialty practice from individual practice;
- an increase in the number of medical assistants, nurse practitioners and physician assistants employed in gynecologic oncology practices;
- a continued dedication to providing chemotherapy services to patients regardless of the changes in reimbursement rates
- the continuation of enrollment of patients into cooperative studies versus the more revenue neutral or positive industry-sponsored trials;
- the positive effect of caps on non-economic and total damages on the cost of medical liability/malpractice insurance; and
- an overall willingness of gynecologic oncologists to accept and treat women with a gynecologic cancer without knowledge of insurance coverage and the preponderance of Medicare and Medicaid patients seen in a practice, versus private insurance.

"This is the most inclusive snapshot of the gynecologic oncology profession available," explained SGO Practice Survey Task Force Chairman James Orr, M.D.  "The information in this report is a useful tool not only to current, practicing gynecologic oncologists with regard to how their practice composition relates to their peers but also has important implications for individuals considering a career in this subspecialty."

He added, the report provides important information to medical schools interested in creating a specialty program and hospitals and health systems investigating the addition of specialized cancer care to their women's healthcare programs.

"The ability to compare and contrast the subspecialty's current climate with that of five years ago gives our profession a concrete idea to the trends in women's cancer care," concludes SGO President, Daniel Clarke-Pearson, M.D. "The study's findings offer a real indication of practice workforce needs, what is required of today's gynecologic oncologist, and a road map for where the profession is heading in the future."

The SGO is a national medical specialty organization of physicians who are trained in the comprehensive management of women with malignancies of the reproductive tract.  Its purpose is to improve the care of women with gynecologic cancer by encouraging research, disseminating knowledge which will raise the standards of practice in the prevention and treatment of gynecologic malignancies, and cooperating with other organizations interested in women's health care, oncology and related fields.  The Society's membership, totaling more than 1,300, is primarily comprised of gynecologic oncologists, as well as other related medical specialists including medical oncologists, radiation oncologists and pathologists.  SGO members provide multidisciplinary cancer treatment including chemotherapy, radiation therapy, surgery and supportive care.  More information on the SGO can be found at www.sgo.org.


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Subscribe Now